Study of Otamixaban Versus Unfractionated Heparin (UFH) and Eptifibatide in Non-ST Elevation Acute Coronary Syndrome

Clinical trial NCT00317395 · COMPLETED

Trial details

NCT number: NCT00317395
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Coronary Disease

Start date: 2006-06-01
Primary completion: 2008-10-01
Enrollment: 3241

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.